493
Participants
Start Date
March 31, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
CAZ-AVI
Ceftazidime 2000 mg and 500 mg of avibactam
Metronidazole
500 mg of Metronidazole
Meropenem
1 gram of Meropenem
Research Site, Chula Vista
Research Site, San Diego
Research Site, St Louis
Research Site, Somers Point
Research Site, Córdoba
Research Site, Rosario
Research Site, Rousse
Research Site, Varna
Research Site, Zagreb
Research Site, Děčín
Research Site, Hradec Králové
Research Site, Jihlava
Research Site, Olomouc
Research Site, Prague
Research Site, Teplice
Research Site, Budapest
Research Site, Székesfehérvár
Research Site, Bangalore
Research Site, Pune
Research Site, Trivandrum
Research Site, Vadodara
Research Site, Hadera
Research Site, Haifa
Research Site, Riga
Research Site, Alor Star
Research Site, Durango
Research Site, Guadalajara, Jalisco
Research Site, Mexico City
Research Site, 's-Hertogenbosch
Research Site, Enschede
Research Site, Arequipa
Research Site, Cercardo de Lima
Research Site, Lima
Research Site, Trujillo
Research Site, Cluj-Napoca
Research Site, Iași
Research Site, Kemerovo
Research Site, Moscow
Research Site, Saratov
Research Site, Vsevolozhsk
Research Site, Pretoria
Research Site, Alcorcón
Research Site, Elche
Research Site, Sabadell(Barcelona)
Research Site, Kaohsiung City
Research Site, Taichung
Research Site, Tainan City
Research Site, Taipei
Research Site, Bangkok
Research Site, Khon Kaen
Research Site, Phisanulok
Research Site, Dnipropetrovsk
Research Site, Ivano-Frankivsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Forest Laboratories
INDUSTRY
Pfizer
INDUSTRY